Immunai Joins 10x To Scale Single Cell Genomics
December 21, 2020
By Allison Proffitt
December 21, 2020 | Immunai has announced its collaboration with 10x Genomics as one of the first 10x Certified Service Providers. Immunai will leverage 10x’s robust single-cell technologies to map hundreds of cell types and states. By applying its proprietary artificial intelligence and machine learning algorithms, Immunai supports biomarker discovery and insight generation to ultimately power new therapeutic discoveries and accelerate drug development.
Immunai was started by Luis Voloch and Noam Solomon about two years, Voloch told
Bio-IT World. The goal is to “revolutionize immunology” by scaling single cell genomics, he said, both in the lab and computationally.